These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

666 related items for PubMed ID: 18627416

  • 21. Interactions between antiepileptic and chemotherapeutic drugs in children with brain tumors: is it time to change treatment?
    Ruggiero A, Rizzo D, Mastrangelo S, Battaglia D, Attinà G, Riccardi R.
    Pediatr Blood Cancer; 2010 Feb; 54(2):193-8. PubMed ID: 19731334
    [Abstract] [Full Text] [Related]

  • 22. Effects of intermittent levetiracetam dosing in a patient with refractory daily seizures.
    Friedman D, French JA.
    Neurology; 2006 Feb 28; 66(4):590-1. PubMed ID: 16505320
    [Abstract] [Full Text] [Related]

  • 23. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP, Ricker L, Diepman L, Gehring J, Hulsman J, Lambrechts D, Leenen L, Majoie M, Schellekens A, de Krom M, Aldenkamp AP.
    Epilepsy Behav; 2007 Mar 28; 10(2):296-303. PubMed ID: 17317325
    [Abstract] [Full Text] [Related]

  • 24. Levetiracetam as an adjunct to phenobarbital treatment in cats with suspected idiopathic epilepsy.
    Bailey KS, Dewey CW, Boothe DM, Barone G, Kortz GD.
    J Am Vet Med Assoc; 2008 Mar 15; 232(6):867-72. PubMed ID: 18341442
    [Abstract] [Full Text] [Related]

  • 25. Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies.
    Patsalos PN.
    Epilepsia; 2005 Mar 15; 46 Suppl 9():140-8. PubMed ID: 16302888
    [Abstract] [Full Text] [Related]

  • 26. Enhanced efficacy of anticonvulsants when combined with levetiracetam in soman-exposed rats.
    Myhrer T, Enger S, Jonassen M, Aas P.
    Neurotoxicology; 2011 Dec 15; 32(6):923-30. PubMed ID: 21570999
    [Abstract] [Full Text] [Related]

  • 27. Interactions between zonisamide and conventional antiepileptic drugs in the mouse maximal electroshock test model.
    Borowicz KK, Luszczki JJ, Sobieszek G, Ratnaraj N, Patsalos PN, Czuczwar SJ.
    Eur Neuropsychopharmacol; 2007 Mar 15; 17(4):265-72. PubMed ID: 16876388
    [Abstract] [Full Text] [Related]

  • 28. Role of levetiracetam in the treatment of epilepsy.
    Brodie MJ, French JA.
    Epileptic Disord; 2003 May 15; 5 Suppl 1():S65-72. PubMed ID: 12915344
    [Abstract] [Full Text] [Related]

  • 29. Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractory epilepsy.
    Lancelin F, Franchon E, Kraoul L, Garciau I, Brovedani S, Tabaouti K, Landré E, Chassoux F, Paubel P, Piketty ML.
    Ther Drug Monit; 2007 Oct 15; 29(5):576-83. PubMed ID: 17898647
    [Abstract] [Full Text] [Related]

  • 30. Antiepileptic drug discovery: lessons from the past and future challenges.
    Klitgaard H.
    Acta Neurol Scand Suppl; 2005 Oct 15; 181():68-72. PubMed ID: 16238713
    [Abstract] [Full Text] [Related]

  • 31. Piracetam and levetiracetam: close structural similarities but different pharmacological and clinical profiles.
    Genton P, Van Vleymen B.
    Epileptic Disord; 2000 Jun 15; 2(2):99-105. PubMed ID: 10954241
    [Abstract] [Full Text] [Related]

  • 32. [Pharmacology and clinical results of levetiracetam (E Keppra(®) Tablets), a new antiepileptic drug].
    Ishii Y, Tanaka T.
    Nihon Yakurigaku Zasshi; 2011 Feb 15; 137(2):95-102. PubMed ID: 21321459
    [No Abstract] [Full Text] [Related]

  • 33. No kinetic interaction between levetiracetam and cyclosporine: a case report.
    Franzoni E, Sarajlija J, Garone C, Malaspina E, Marchiani V.
    J Child Neurol; 2007 Apr 15; 22(4):440-2. PubMed ID: 17621525
    [Abstract] [Full Text] [Related]

  • 34. Levetiracetam in brain ischemia: clinical implications in neuroprotection and prevention of post-stroke epilepsy.
    Belcastro V, Pierguidi L, Tambasco N.
    Brain Dev; 2011 Apr 15; 33(4):289-93. PubMed ID: 20630672
    [Abstract] [Full Text] [Related]

  • 35. Levetiracetam: treatment in epilepsy.
    Ben-Menachem E.
    Expert Opin Pharmacother; 2003 Nov 15; 4(11):2079-88. PubMed ID: 14596661
    [Abstract] [Full Text] [Related]

  • 36. Clinical pharmacology of new antiepileptic drugs.
    Willmore LJ.
    Neurology; 2000 Nov 15; 55(11 Suppl 3):S17-24. PubMed ID: 11147564
    [Abstract] [Full Text] [Related]

  • 37. Seizure control with antiepileptic drug therapy in 517 consecutive adult outpatients at the Kork Epilepsy Centre.
    Steinhoff BJ, Maren Staack A, Wisniewski I.
    Epileptic Disord; 2012 Dec 15; 14(4):379-87. PubMed ID: 23274162
    [Abstract] [Full Text] [Related]

  • 38. Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy.
    Specchio N, Boero G, Michelucci R, Gambardella A, Giallonardo AT, Fattouch J, Di Bonaventura C, de Palo A, Ladogana M, Lamberti P, Vigevano F, La Neve A, Specchio LM.
    Epilepsia; 2008 Apr 15; 49(4):663-9. PubMed ID: 18266754
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics of levetiracetam in infants and young children with epilepsy.
    Glauser TA, Mitchell WG, Weinstock A, Bebin M, Chen D, Coupez R, Stockis A, Lu ZS.
    Epilepsia; 2007 Jun 15; 48(6):1117-22. PubMed ID: 17442002
    [Abstract] [Full Text] [Related]

  • 40. Levetiracetam Clinical Pharmacokinetic Monitoring in Pediatric Patients with Epilepsy.
    Tan J, Paquette V, Levine M, Ensom MHH.
    Clin Pharmacokinet; 2017 Nov 15; 56(11):1267-1285. PubMed ID: 28353057
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.